TRADING UPDATE – October 2025

Summary by AI BETAClose X

RELX reported strong underlying revenue growth of 7% for the first nine months of 2025. The company anticipates another year of strong underlying growth in revenue and adjusted operating profit, alongside strong growth in adjusted earnings per share on a constant currency basis. Risk saw underlying revenue growth year-to-date at 8%. Scientific, Technical & Medical experienced underlying revenue growth year-to-date of 5%. Legal saw underlying revenue growth year-to-date of 9%. Exhibitions reported underlying revenue growth year-to-date of 8%. The company expects continued strong underlying revenue growth with underlying adjusted operating profit growth slightly exceeding underlying revenue growth.

Disclaimer*

Companies

Relx plc (REL)
UK 100